KemOne ranked among the top searched stocks for 3 days in the past month.
As of 2:31 PM on the 27th, KemOne is trading at 3,815 KRW, down 6.03% from the previous day. This represents a 98.18% increase compared to July 29. KemOne is known as the first non-clinical CRO company in Korea.
Over the past 5 days, individual investors have sold a net 293,805 shares, while foreigners and institutions have bought a net 43,666 shares and 171,059 shares, respectively.
On August 24, KemOne became a market issue with the headline "SK Bioscience benefit leads to 18% increase."
※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
